Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide

Akiko Hashimoto; Yasuhiro Tanaka; Takayuki Ishikawa; Isaku Shinzato

doi:10.1002/ccr3.4417

Clinical Case Reports (Jul 2021)

Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide

Akiko Hashimoto,
Yasuhiro Tanaka,
Takayuki Ishikawa,
Isaku Shinzato

Affiliations

Akiko Hashimoto: Department of Hematology and Clinical Immunology Kobe City Nishi‐Kobe Medical Center Kobe Japan
Yasuhiro Tanaka: Department of Hematology and Clinical Immunology Kobe City Nishi‐Kobe Medical Center Kobe Japan
Takayuki Ishikawa: Department of Hematology Kobe City Hospital Organization Kobe City Medical Center General Hospital Kobe Japan
Isaku Shinzato: Department of Hematology and Clinical Immunology Kobe City Nishi‐Kobe Medical Center Kobe Japan

DOI: https://doi.org/10.1002/ccr3.4417
Journal volume & issue: Vol. 9, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords